PRME
Prime Medicine Inc.
$3.24
-$0.20(-5.81%)
61
Overall
--
Value
83
Tech
39
Quality
Market Cap
$488.50M
Volume
3.04M
52W Range
$1.11 - $5.17
Target Price
$6.50
EPS Estimates Overview
| Current Quarter | $-0.28 | Next Quarter | $-0.24 |
| Current Year | $-1.23 | Next Year | $-0.96 |
| QoQ Growth | +14.3% | YoY Growth | +22.0% |
| 3Y EPS CAGR | +26.7% | Target Price | $6.50 |
| Consensus | Buy | Upside | +100.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $3.24 | -5.8% | 3.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |